From Prolonging Life to Pursuing Cure: How Immunotherapy Is Shifting Expectations

Aiwu (Ruth) He, PhD, MedStar Georgetown University Hospital, is joined by Mark Yarchoan, MD, Johns Hopkins Medicine; James Harding, MD, Memorial Sloan Kettering Cancer Center; and Namrata Vijayvergia, MD, Fox Chase Cancer Center, for a roundtable discussion on the current and future treatment considerations for advanced HCC.

The panel explores how treatment goals in advanced HCC have evolved, particularly in light of unpredictable long-term responders to immunotherapy. They discuss the balance between extending survival and preserving quality of life, noting the individual nature of care. The

Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

Conference Coverage